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Insect pests are a major cause of crop losses worldwide, with an estimated economic cost of
$470 billion annually. Biotechnological tools have been introduced to control such insects
without the need for chemical pesticides; for instance, the development of transgenic plants
harbouring genes encoding insecticidal proteins. The Vip3 (vegetative insecticidal protein 3)
family proteins from Bacillus thuringiensis convey toxicity to species within the Lepidoptera,
and have wide potential applications in commercial agriculture. Vip3 proteins are proposed to
exert their insecticidal activity through pore formation, though to date there is no mechanistic
description of how this occurs on the membrane. Here we present cryo-EM structures of a
Vip3 family toxin in both inactive and activated forms in conjunction with structural and
functional data on toxin–membrane interactions. Together these data demonstrate that
activated Vip3Bc1 complex is able to insert into membranes in a highly efficient manner,
indicating that receptor binding is the likely driver of Vip3 specificity.
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Pest insects are a major cause of crop losses
1 worldwide, both
by direct damage to plants and via the spread of plant
diseases that reduce yields. These losses threaten global
food security and the economic viability of crop farming. Bio-
technology is a rich source of strategies for controlling insect pests
that, in turn, circumvent the use of chemical pesticides that
damage the environment. Furthermore, the potential increase in
yields and decrease in pesticide use have the potential to trans-
form the carbon footprint of agriculture2. One approach that has
gained considerable interest is to create transgenic plants
expressing pesticidal proteins from the bacterium Bacillus thur-
ingiensis (Bt). These proteins are active against many families of
insect pests in a species and life-cycle specific manner, but have
no activity against non-target organisms, therefore imparting
highly specific insecticidal activity.
The majority of the pesticidal proteins utilised in transgenic
crops to date belong to the 3-domain family of Cry toxins (3D-
Cry) from Bt, which have been deployed commercially since the
early 1990s3. This approach was initially successful, but resistance
has arisen amongst target insects. Subsequently, efforts have been
made to combine multiple toxins in ‘pyramids’ in order to
combat resistance4. If this combinatorial approach is to be fully
realised we need to understand more about the structure, func-
tion and mechanism of other families of pesticidal proteins, so
they might be properly deployed synergistically. Furthermore, a
molecular level understanding of toxin structure might facilitate
rational redesign of Bt-proteins for increased specificity and/or
potency.
Vip3 toxins are produced by Bt strains during the vegetative
growth phase, and act in a species specific manner against insects
in the order Lepidoptera, which includes some of the most
damaging insect pests5. Vip3Aa variants have already seen suc-
cess in commercial transgenic corn and cotton varieties6.
The Vip3 family of proteins bear no appreciable sequence
homology with other toxins for which the atomic structures have
been determined (including 3D-Cry), and as such, interrogation
of their mechanism of toxicity is of particular interest.
The mechanism by which Vip3 proteins kill insects has been
broadly characterised but the precise details remain unclear7. The
Vip3 proteins have molecular masses of ~90 kDa, and are secreted
as soluble proteins that form tetramers in solution8. They can be
proteolytically processed by trypsin or insect gut extracts to yield
products of ~65 kDa and ~21 kDa that remain closely associated
in solution8,9. This proteolytic processing has been shown to be
required for Vip3 cytotoxicity10,11. In the midgut of susceptible
larvae, the toxin binds to receptors on target cells that are not yet
fully characterised12,13. At some stage following receptor engage-
ment, the Vip3 proteins are proposed to form pores in insect cell
membranes10. These findings suggest that toxicity is likely to
result from pore formation leading to cell necrosis, however, other
mechanisms of toxicity have been suggested including the initia-
tion of apoptosis14.
A flurry of recent structural information has been released for
Vip3 complexes, including an X-ray crystallography structure of
non-native, unprocessed VIP3B216015, and cryoEM structures of
Vip3Aa16 in its unprocessed and activated forms (released while
this manuscript was under review)16. These structures, along with
those presented here, offer insight into the architecture and
mechanism of Vip3 activation and toxicity. Here, we reconstitute
Vip3Bc1 activity in vitro and demonstrate its propensity to per-
turb membranes. Furthermore, we present the structure of wild-
type Vip3Bc1 variant in its pre-processed (autoinhibited) and
processed (activated)(Vip3Bc1act) states and visualise Vip3Bc1act
inserted into liposomes via cryo-electron tomography (cryoET)
allowing us to observe the activated form of the toxin in the
biologically relevant environment of the membrane.
Results
Structure of Vip3Bc1. We first examined the structure of the






















Fig. 1 Structure of Vip3Bc1. A Quaternary structure of Vip3Bc1 tetramer as shown from two views of the complex related by 90° for the EM density (i, ii)
and model (iii, iv). BModel of Vip3Bc1 illustrating domain structure as a monomer. The model shown corresponds to subunit A. Primary trypsin processing
site K205 is indicated. Domain structure with respect to the primary sequence can be seen in Supplementary Fig. 4.
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Vip3Bc1 was recombinantly expressed in Pseudomonas fluor-
escens and purified as previously described9. It was determined to
be monodisperse in solution by size exclusion chromatography
(SEC), and a single peak was observed at the elution volume
anticipated for a Vip3Bc1 tetramer (Supplementary Fig. 1). The
3D reconstruction of the tetrameric assembly of Vip3Bc1 with a
global resolution of 3.9 Å resolution was obtained (0.143 FSC
threshold) (Supplementary Figs. 2, 3). The architecture for the
complex is consistent with that of the recently determined
structures of mutant Vip3 variant Vip3B2160 and with the
cryoEM structure of Vip3Aa1615,16.
Our Vip3Bc1 structure reveals a tetrameric assembly with
C2 symmetry (Fig. 1). Each tetramer comprises two dimers
formed by conformationally distinct A:B monomers. Each
monomer of Vip3Bc1 consists of 5 domains (Fig. 1B). Together,
domain 1 and domain 2 form the N-terminal, largely alpha-
helical portion of the protein. We have defined domains based on
the architecture of the unprocessed tetramer previously used15
(Supplementary Fig. 4). The two domains are connected by a
contiguous alpha-helix (α3, residues 94-162) that interfaces with
α2 (residues 61-88) undertaking a super-helical twist that gives
the complex a distinct conical appearance. Domains 3-5 make up
the C-terminal portion of the protein, primarily composed of β-
strands. The interchain interactions that bring about the conical
morphology and impart the C2 symmetry are formed at the
interface between domains 1 and 2 on each of the monomers,
with the rest of the complex not involved in oligomerisation.
Using this cryoEM density map in conjunction with the recently
deposited crystal structure coordinates of the mutant protein
Vip3B2160 (PDB 6V1V), we generated a complete atomic model
for each A:B monomer, which together with symmetry operations
yield a model of the bioassembly.
Proteolytic processing of Vip3Bc1. To investigate the structure
and activity of proteolytically cleaved Vip3Bc1, we performed a
trypsin digest to yield two primary digestion fragments of ~68 kDa
and ~21 kDa respectively, which we term activated Vip3Bc1
(Vip3Bc1act) (Supplementary Fig. 1). Mass spectrometry analysis
indicates that these fragments are formed primarily by digestion at
K205 (Supplementary Fig. 5). This result differs to those observed
in previous studies, which report Vip3Bc1 digestion with Lepi-
dopteran midgut enzymes occurs primarily at K2139. This dis-
crepancy could be attributed to the differing digestive enzymes
used in each study, and could point to redundancy in the acti-
vation mechanism of Vip3Bc1, with cleavage at a number of
locations on this loop yielding active toxin. Both of these cleavage
sites are present on a solvent exposed loop of domain 2, allowing
proteases to access these residues inside the insect gut. Consistent
with previous reports, we saw no evidence for the first 20 N-
terminal residues, which sit prior to the cleavage site (*) in the
R*ALPSF site which is well conserved amongst all known sub-
families of Vip3 proteins (Supplementary Fig. 4)9.
To investigate the differing propensity of Vip3Bc1 and
Vip3Bc1act to perturb membranes, dye release assays were
performed, exposing DOPC and DOPE (6:4) unilamellar vesicles
(LUVs) loaded with 5(6)-carboxyfluorescein (CF), to Vip3Bc1
and Vip3Bc1act protein at varying concentrations. This lipid
composition was chosen as insect membranes are highly enriched
in PE17. Based on previous reports which state that Vip3Aa35
membrane perturbation in calcein release assays was of greatest
magnitude at pH 8, and not active at pH 10 (ref. 10), we
conducted our dye release assays at pH 8.5, and measured
perturbation after 30 min in order to obtain ‘end point’ data.
These data demonstrate that the digested Vip3Bc1act has a much
higher propensity to perturb LUVs than undigested protein
(Fig. 2A), with >100-fold more Vip3Bc1 being required to achieve
a similar magnitude of perturbation achieved by Vip3Bc1act. The
activated toxin Vip3Bc1act perturbs membranes in a dose
dependent manner (Fig. 2A).
To interrogate the structural basis for VipBc1act enhanced ability
to perturb membranes, we analysed the complex by single particle
cryoEM. We obtained a 3D reconstruction of the digested complex
by single particle cryo-EM analysis to a global resolution of 4.8 Å
(0.143 FSC threshold) (Fig. 2 B-C, Supplementary Figs. 3, 6). The
structures reveal that Vip3Bc1 to VipBc1act transition requires
extensive conformational rearrangements, but consistent with
previous biochemical analyses, retains its tetrameric state8 while
opening an approximately 5 Å pore (Fig. 2 D,E). This structure is
in marked contrast to the recently reported crystal structure of
Vip3Aa11200-end, (completely deleting the cleaved N-terminal
region) where the truncation likely resulted in a non-native
structure18. The Vip3Bc1act dataset shows a strong preferred
orientation compared with Vip3Bc1 (Supplementary Fig. 3); to
generate our 3D structure we used a tilted collection strategy19. The
shift in angular orientation distribution may be indicative of
changes in surface charge/hydrophobicity altering the particles’
interactions with the air-water interface20. The preferred orienta-
tion produced a Vip3Bc1act cryoEM map with pronounced
anisotropy and of poorer quality than the recently reported
cryoEM structure of activated Vip3Aa16. We were not able to
directly observe density for an extended alpha-helical bundle in our
single particle cryoEM reconstruction of Vip3Bc1act, however we
were able to use deposited Vip3Aa16 coordinates to generate a
model for Vip3Bc1act EM density due to high sequence identity
(59.9%).
It has been widely proposed that Vip3 proteins impart their
toxicity via pore formation. To inform our understanding of
pore formation by Vip3Bc1, we used cryo-ET to directly
observe Vip3Bc1act interaction with the membrane. We
prepared cryoEM grids of LUVs incubated with either Vip3Bc1
or Vip3Bc1act and imaged using cryoET. We observed that
Vip3Bc1act associated with the membrane in an elongated ‘open
umbrella’ conformation, ~15–18 nm on its longest dimension
to the membrane, with a stalk interacting with the membrane
and the bulk of the protein density distal to the membrane
(Fig. 3, Supplementary Movie 1). These data support the model
that activated Vip3 toxins interact with the membrane via an
extended helical bundle, and is consistent with negative stain
EM images of a Vip3Aa3510 and the recently published
structure of Vip3Aa1616, suggesting that this conformational
change upon digestion may be common across Vip3 variants.
Inspection of the tomograms reveals the stalk penetrating the
membrane (Supplementary Movie 2).
In addition to single Vip3Bc1act tetramers imaged on the
membrane, we also observed instances where individual lipo-
somes were highly enriched in Vip3Bc1 particles (Supplementary
Movie 3). However, in the majority of tilt series collected, we were
unable to observe protein interacting with the membrane. In
tomograms of LUVs exposed to undigested Vip3Bc1, we were not
able to identify any Vip3Bc1 binding to the membrane, although
protein aggregates were observed in some tomograms (Supple-
mentary Movie 4).
Discussion
Vip3Bc1 domain structure. The liposome dye release data pre-
sented here support the hypothesis that activated Vip3 imparts its
toxicity via membrane pore formation. In this respect, Vip3 is
reminiscent of 3D-Cry proteins, which induce cell death through
insertion into insect gut membranes, pore formation and
ultimately cell death by lytic osmosis21. Whilst analysing our
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Vip3Bc1 domain structures, we observed that they bear striking
structural homology to domains found in the 3D-Cry toxin
family of proteins, despite sharing no similarity at the primary
sequence level (Fig. 4). It is, therefore, reasonable to speculate that
each of the domains in Vip3Bc1 may carry out similar activities to
their counterpart component in the more widely studied 3D-Cry
proteins.
Domain 2 of Vip3Bc1 shares the same protein fold as domain 1
of 3D-Cry proteins, which is proposed to play a role in membrane
perturbation (Fig. 4). Each has a predominantly hydrophobic
alpha helix surrounded by five other helices in a helical bundle. A
proposed mode of action of 3D-Cry proteins involves the hinge
movement of two helices of the helical bundle into a roughly
equivalent position of α2 and α3, which form the conical tip of
Vip3Bc122. This suggests that this architecture is an integral part
of the mode of action of both Vip3Bc1 and 3D-Cry toxins.
Vip3Bc1 domain 3 is structurally similar to domain 2 from 3D-
Cry proteins, which has a role in receptor binding in 3D-Cry23.
Both share a beta prism fold with three sides made up of
antiparallel beta sheets (Fig. 4). Recent studies support the role of
domain 3 in receptor recognition in Vip318. The regions
equivalent to the Vip3Bc1 domain 3 loop I488-T492 show high
levels of variability between Vip3A, Vip3B and Vip3C proteins
(Supplementary Fig. 4) but the significance of such loops to the
target specificity of toxins remains to be established. Preceding
this loop is a region where Vip3B toxins are distinct from other
Vip3 variants in that they have additional inserted residues
(residues 476-484 in Vip3Bc1 and 10 residues longer in Vip3Ba1
and Vip3Bb1, Supplementary Fig. 4). Deletion of this insert was
one of several mutations introduced in order to elucidate the only
existing Vip3B structure, mutant VipB216015. In Vip3Bc1 the






















Fig. 2 Vip3Bc1act has a greater propensity to perturb liposome membranes compared with Vip3Bc1. A Digestion of the complex increases activity
according to CF dye release from LUVs upon addition of Vip3Bc1act (red) and Vip3Bc1 (grey). Plotted data represents the mean and the error bars the
standard deviation of the measurements from three independent replicates (Full data shown Supplementary Table 3 and 4). B Quaternary structure of
Vip3Bc1act tetramer as shown from two views of the complex related by 90° for the EM density (I, ii) and model (iii, iv). CModel of Vip3Bc1act asymmetric
unit, illustrating domain structure as a monomer. D Vip3Bc1act tetrameric assembly as shown from the top conformation is consistent with a pore. E Pore
structure of Vip3Bc1act.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-23146-4
4 NATURE COMMUNICATIONS |         (2021) 12:2791 | https://doi.org/10.1038/s41467-021-23146-4 | www.nature.com/naturecommunications
short alpha helices in domain 3, which sit exposed in the
tetrameric assembly.
Domains 4 and 5 of Vip3Bc1 bear striking structural similarity
to each other, with superposition yielding an RMSD of 5.9 Å
despite low sequence identity (22%), with a twisted beta-sheet ‘jelly
roll’ fold that they share with domain 3 of the 3D-Cry proteins
(Fig. 4). Domain 3 of 3D-Cry proteins has been implicated in target
specificity and glycan binding in previous studies24. The role of
Vip3 domains 4 and 5 in target insect specificity may be supported
by other studies that showed mutation of residues in domain 4 of
Vip3Aa11 altered toxicity levels against Spodoptera exigua and
Helicoverpa armigera25 and alanine scanning mutagenesis of the
Vip3Af1 protein identified a number of mutants in this region that
caused significant loss of activity against Spodoptera frugiperda and
Agrotis segetum26. Furthermore, DALI analysis of domains 4 and 5
of Vip3Bc1 identified a number of structural homologues of
these domains with putative and demonstrated glycan binding
capabilities27. It is therefore reasonable to suggest that these
domains may play a role in receptor engagement.
Structural variation in the Vip3 family. Several structures have
been released for Vip3 variants recently15,16,18. Structures of the
unprocessed Vip3, including that for Vip3Bc1 presented here,
show the same overarching morphology in their bioassembly
(Supplementary Fig. 7). When inspected at the primary sequence
level, Vip3 variants share a high degree of sequence identity, and
consequently structural identity, particularly in domains 1 and 2
which are involved in proteolytic activation, and the global
conformational change observed between Vip3Bc1 and Vip3B-
c1act. We can use the recent findings to propose that all
Vip3 share a common mechanism of activation and action.
However, subtle structural differences are observed between
Vip3 structures available to date. Domains 3–5 show a much
higher degree of sequence divergence across the Vip3 family,
which is reflected in differing relative orientations of domains 3, 4
and 5 when comparing Vip3Bc1 and Vip3Aa16 (Supplementary
Fig. 7). In the Vip3Aa16 structure, loops on domain 5 appear to
dock into pockets in domain 3, with interacting residues well
conserved within Vip3A but not within Vip3B and C. In addition,
Vip3Bc1 domain 3 has extended insert sequences (Supplementary
Fig. 4). This leaves domain 5 to occupy a distinct orientation
relative to domain 3 in Vip3Bc1 vs Vip3Aa16. Structural
variations in domains 3–5 might underpin the difference in
target species specificity that we see amongst different Vip3
toxins. These recent structural insights provide the basis for
interesting future experiments to tailor toxin specificity.
Activation and membrane interaction. Bringing structural and
biochemical data together, we propose a model for this structural
rearrangement and mechanism of action in the context of the
biological assembly (Fig. 5). After cleavage at K205 the remaining
helices of domain 2 that are C-terminal to the cut site (from helix
α5 onwards), remain in essentially their original position stabi-
lising the central interface of the tetramer. The dramatic changes
induced by proteolysis arise from the liberation of residues N-
terminal to the cleavage site, and we propose this conformational
change cannot occur in the absence of cleavage on the K205 loop.
Following cleavage, inter-subunit interactions at the conical tip of
the complex dissociate, allowing for helices α1–α3 to rotate and
move down through the gap between the ‘propeller’ regions of
adjacent monomers, and form the extended helical bundle at the
base of the complex, as visualised via cryoET (Fig. 3) and con-
sistent with the reports for Vip3Aa1616. The tips of this helical
bundle may then insert into the membrane, and in doing so form
a pore. The segmented cryoET data illustrates that the model built
for Vip3Bc1act does not have a sufficiently long alpha-helical
bundle to fully accommodate the cryoET density. While models
for other Vip3 variants16 have proposed longest dimension of the
activated complex to be ~24 nm, in the cryoET data presented
here we only see ~15 nm of density outside of the membrane.
This supports the view that we are observing Vip3Bc1act inserting




Fig. 3 Vip3act directly visualised on liposome membranes. Segmented density from cryo-ET shows interaction of Vip3Bc1act (coloured) with the LUV
membrane (white). Images inset show section through the tomogram of the matching particle in segmentation. Full tomogram can be visualised in
Supplementary Movie 1. Scale bar 20 nm. B Scaled comparison between segmented density for a single particle in the tomogram, with 5 nm scale bar (i)
compared to Vip3Bc1act model (ii) with an overlay showing the stalk density fits the 4-helix bundle well, and the density which is distal to the membrane is
consistent with single particle Vip3Bc1act model. The helical stalk modelled in Vip3Bc1act does not account for all of the stalk density observed in the sub-
volume.
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we propose acts to shuttle small ions following membrane
insertion, and therefore imparts the membrane perturbing
activity of Vip3Bc1.
The liberated helices α1-3 (Fig. 5) are structurally mobile and
not observed in our Vip3Bc1act structure. We propose that, at
least in Vip3Bc1, these helices are relatively flexible in solution.
However, our cryoET data clearly show a stalk (Fig. 3) consistent
with a conformational change of Vip3Bc1, in which these helices
form a membrane pore. Density for the stalk was also observed in
the Vip3Aa structure. This may indicate that, in solution, the
Vip3Aa16 stalk is more stable than that of Vip3Bc1, or
alternatively the continuous carbon surface on the cryoEM grid
may have stabilised the stalk region of Vip3Aa1616.
Image analysis of the Vip3Bc1 and Vip3Bc1act revealed
heterogeneity, with populations of both structural conformers
present in all datasets. We were able to classify a subset of
particles from the Vip3Bc1 dataset into a 3D class corresponding
to the activated conformation (Supplementary Fig. 2). For
Vip3Bc1act, SDS-PAGE gel analysis indicates almost complete
digestion of the complexes (Supplementary Fig. 1), but ~16% of
particles in the Vip3Bctact population classified into a 3D
structure corresponding to Vip3Bc1 (Supplementary Fig. 6). This
could represent tetrameric complex where one or more of the
monomers remains unprocessed, which may hold the partially
digested complex in the Vip3Bc1 conformation. However other
factors may also contribute to the initiation of the conformational
change, as in the case of Vip3Aa35 ~30% of proteolytically
activated protein was reported to remain in the inactivated
conformation despite >95% processing reported.
Particles adopting Vip3Bc1act -like conformation were also
found in the Vip3Bc1 dataset (Supplementary Fig. 2). This
suggests (i) that cleavage on the loop containing K205 is not
needed for conformational change or (ii) that between SDS PAGE
analysis and imaging by cryoEM, cleavage occurred, enabling the
conformational change. While this remains an unexplained
observation, based on the structures available we believe that
cleavage on the K205 loop is required for conformational change
to take place, given the large steric clashes that would result if the
conformational change was attempted without cleavage of all four
monomers.
Significantly, in our cryoET data we are clearly visualising the
Vip3Bc1act interacting with the membrane via the stalk region,
and we propose that this shows the physiologically relevant pore
conformation. Comparisons of tomograms of Vip3Bc1 show a
large variation in the number of protein molecules observed
bound to the membrane. The majority of LUVs imaged did not
have protein bound, while a small number of LUVs were highly
enriched in Vip3Bc1 (Supplementary Movie 2). This finding
suggests that Vip3Bc1act particles likely bind to the first
membrane they encounter in solution, in a diffusion limited
manner. When taken together with the liposome dye release assay
results, these data suggest that receptor engagement is not
necessary for activated Vip3 to insert into membranes and impart
its membrane perturbing toxicity. This phenomenon is also
observed with other pore-forming proteins, including 3D-Cry
toxins, which can form pores in artificial membranes independent
of a receptor28–30. However, the in situ activity of activated Vip3
on the biomembrane may also be influenced by factors including
lipid composition, integral or membrane associated proteins and
glycosylation. We note that the concentration of toxin present in
our experiments likely does not reflect that present in the gut of
target insects—where receptor engagement likely acts to capture
toxin at the membrane thereby increasing the effective concen-
tration. Existing structural data do not illuminate whether
receptor engagement happens before or after processing, indeed
receptor engagement may occur in both conformations. Further
studies are required to shed light on this area.
The dimensions of the complex observed on the membrane via
cryoET indicate that only a small portion of the extended helical
stalk would insert into the membrane. This is reminiscent of the
proposed activity of other alpha-helical pore forming toxins such
as the YaxAB toxins31 and HlyE (also known as ClyA32.
Previous biochemical analysis has suggested that Vip3Aa
complex forms a pore in membranes of 14 Å in a planar lipid
bilayer at pH 8.010, consistent with structures of activated Vip3
presented here and elsewhere. The proposal that domains 1 and 2
of Vip3 proteins are involved in pore formation is supported by
alanine scanning mutagenesis experiments that highlighted a
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Fig. 4 Structural homology of Vip3 domains to counterpart 3D-cry
domain. Structural homology of Vip3 domains to counterpart 3D-cry
domain. A Vip3Bc1 domain 2 and 3D-Cry domain 1 (Cry1A domain 1, PDB
6DJ4 shown) share a predominantly hydrophobic alpha helix surrounded by
other helices in a bundle. B Vip3Bc1 domain 3 and 3D-Cry domain 2 (Cry1A
domain 2 PDB 6DJ4) share a beta prism fold with three sides made up of
antiparallel beta sheets. C Domains 4 Vip3Bc1 and 3D-Cry domain 3 (Cry1A
domain 3, PDB 6DJ4 shown) share a twisted beta-sheet ‘jelly roll’ topology.
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Vip3Af1 protein (a domain 2 region equivalent to residues
177–282 of Vip3Bc1) that caused significant loss of activity
against S. frugiperda and A. segetum26. We would propose that
these mutants may interfere with the pore forming role of
domain 2.
Several important outstanding questions remain about how
Vip3 exerts its cytotoxicity in situ. Vip3Bc1 is thought to exert its
toxic effect in the lepidopteran midgut, a high pH (>pH 10)
environment33, however here we demonstrate that Vip3Bc1act is
highly active at pH 8.5, and previous biochemical studies show
Vip3Aa35 is inactive (and aggregates) at pH 10 (ref. 10). Taking
these data together, we suggest Vip3 toxins must be processed
and exert their pore forming action in a more pH neutral
environment than that of the high pH midgut lumen. Two
possibilities may allow for this, firstly that regional microenvir-
onments exist within the midgut and allow pore formation to
occur. Alternatively, the Vip3 tetrameric complex may be
internalised to intracellular compartments before exerting its
cytotoxic effects. The generation of neoepitope antibodies or
other protein conformation specific binders that can distinguish
between Vip3 and Vip3act could be important tools to help
address these questions in a cellular context.
In summary, our study gives insight into the mechanism by
which activated Vip3 complexes perturb membranes. Further
analysis of the Vip3 family of toxins will be required to shed light
on their cytotoxicity in situ, and on the role of receptor
engagement in species specificity of different Vip3 variants.
Methods
Purification of Vip3Bc1. The Vip3Bc1 protein was expressed in Pseudomonas
fluorescens and purified as previously described9. For undigested Vip3Bc1, the
protein (1 mg/mL) was loaded onto a pre-equilibrated Superose 6 increase 10/300
GL column (25 mM TrisHCl pH 7.5 and 150 mM NaCl). For the trypsin digest,
Vip3Bc1 (1 mg/mL, 25 mM TrisHCl pH 8 150 mM NaCl) was incubated with
trypsin (1:100 molar ratio) and incubated at 37 °C for 1 h. The sample was then
loaded onto a pre-equilibrated Superose 6 increase 10/300 GL column with 25 mM
TrisHCl pH 7.5 and 150 mM NaCl.
CryoEM grid preparation. Protein for single particle analysis was prepared using
Quantifoil R 1.2/1.3 Cu 300 grids, glow-discharged in air using the Quorum
GloQube® for 30 s at 40 mA (Vip3Bc1) or plasma cleaned using a Tergeo-EM
plasma cleaner (Pie Scientific) (Vip3Bc1act). 3 µL of sample was applied to the grids
in a Vitrobot Mark IV (Thermo Fisher Scientific) at 95% relative humidity, 4 °C,
blotted for 6 s with a blot force of ‘6’ and plunged into liquid ethane.
For grids containing LUVs, samples were vitrified ~6 h after LUV and protein
were mixed. LUV solution was mixed 2:1 with a concentrated stock of 10 nm
fiducial markers resuspended in the same buffer as LUVs. Quantifoil R 2/2 Cu 200
grids were glow-discharged in air in a Quorum GloQube® for 30 s at 40 mA prior
cryoEM grid preparation. 3 µL of sample was applied to the grids in a Vitrobot
Mark IV (Thermo Fisher Scientific) at 95% relative humidity, 4 °C, blotted for 6 s
with a blot force of ‘6’ and plunged into liquid ethane.
CryoEM imaging. Single particle cryoEM data were collected on a Titan Krios
microscope (‘Titan Krios 1’ at the Astbury Biostructure Laboratory) operating at
300 kV and Falcon III direct electron detector (Thermo Fisher Scientific) operating
in integrating mode. Data were collected using EPU software with parameters as in
Supplementary Table 1, based on a published protocol34. Where the sample was
tilted during collection, the autofocus and drift measurements were taken in line
with the tilt axis.
Tilt series data were collected using a Titan Krios microscope (‘Titan Krios 2’)
operating at 300 kV and Bioquantum energy filter (20 eV) K2 direct electron
detector (Gatan) operating in counting mode, using Tomo software (Thermo
Fisher Scientific). Data were collected with parameters as in Supplementary
Table 2.
Single particle cryoEM data processing. All frames of each micrograph movie
were motion-corrected, dose weighted, and merged using Motioncor235. The
contrast transfer function (CTF) for each micrograph was determined using Gctf36
on motion-corrected, but non-dose weighted, micrographs. Particles were selected
with crYOLO37 using the PhosaurusNet general model. Individual particles were
extracted into 264 × 264 pixel (281 Å) boxes for Vip3Bc1 or 300 × 300 pixel (320 Å)
boxes for Vip3Bc1 and culled with multiple rounds of 2D classification in Relion
338. Asymmetric starting models were created in Relion 3 using stochastic gradient
descent (SGD)39 and manually aligned on the C2/C4 symmetry axes using UCSF
Chimera40. The particles were further culled by multiple rounds of 3D classification
(heterogeneous refinement) in cryoSPARC. Heterogenous refinements for Vip3Bc1
were performed first with two copies of the SGD model as references, and sub-
sequently with two copies of the best result from the previous reconstruction in
later iterations. Heterogenous refinements for Vip3Bc1 were first performed with
three copies of the SGD model as references, followed by two copies of the previous
best result and one copy of the undigested Vip3Bc1 to remove images of undigested
particles, and finally two copies of the best result from the previous iteration. All
reference models were filtered to 20 Å and heterogenous reconstructions performed
with C2 symmetry applied. Final reconstructions were performed in cryoSPARC
using non-uniform refinement for Vip3Bc1 (C2 symmetry applied) and homo-
genous refinement for Vip3Bc1 (C4 symmetry applied). (Supplementary Fig. 2).
3DFSC were calculated using Remote 3DFSC19.
Classification for determination of proportion of cleaved particles in the
untreated dataset. The 957,014 particles generated from the Vip3Bc1 2D classi-
fication were subjected to one round of heterogenous refinement in cryoSPARC
using two copies of the starting model generated by SGD. One of the two starting
models was unambiguously of the complex Vip3Bc1 whilst the other was unclear.
The ambiguous model was subject to an additional round of heterogenous
refinement in cryoSPARC using two copies of the Vip3Bc1 and one copy of
Vip3Bc1 generated from the trypsin-treated sample. This resulted in three classes:
one, which contained ~31% of the original particles were unambiguously the
cleaved Vip3Bc1 (Supplementary Fig. 6). All refinements were performed with
C1 symmetry.
Tilt series data processing. Image processing was carried out identically for all
tomograms presented. Micrograph movies were frames of each micrograph movie
were motion-corrected and merged using Motioncor2. Tilt series were processed
and constructed into tomograms using fiducial-less alignment in IMOD (bin2)41.
Reconstructed tomograms were filtered in Fiji42 using a 3D gaussian (2 sigma) filter
and adjusted for brightness and contrast to aid visualisation. Tomograms were
segmented using Amira (Thermo Fisher Scientific), using the interactive thresh-
olding tool to segment density.
Model building. The Vip3Bc1 pre-processed map was of sufficient quality to allow
for secondary structure assignment to the core helical domain (domain 1). Initial
secondary structure fragments were generated using Bucaneer and extended
manually in COOT (residues 27–398). The density for domains 2–4 of Vip3Bc1
were of insufficient resolution to allow for de novo model building, for this portion
i ii iii iv v vi
Fig. 5 Proposed model of Vip3Bc1 conformational rearrangement upon processing. Cleavage at K205 liberates helices α1-α4 allowing dissociation of
inter-subunit interactions at the tip of the complex (i), the helices of domains 2 that are C-terminal to the cut site (from α5 onwards), remain in essentially
their original position stabilising the central interface of the tetramer. The α4 helices form a central helical bundle while the other helices N-terminal to the
cut site (α1-3) are able to unfurl and move down between the propeller domains to form a new helical bundle (ii–v), which interacts with the membrane via
the ends of the helical bundle (vi).
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of the model, domains 2–4 from PDB 6V1V were used to generate homology
models of Vip3Bc1. Homology modelling was carried out with the SWISS model
server. The resultant models were rigid body fitted into the cryoEM map using
UCSF chimera and showed good agreement with experimental map. Local fitting of
residues and connectivity of domains was carried out in COOT. The register of
amino acid sequence for Vip3Bc1 was cross referenced with that of PDB 6V16 to
ensure correct assignment in lower resolution areas of the map.
The Vip3Bc1act map was not of sufficient resolution to allow for de novo model
building. Instead residues 105-336 corresponding to domains 1 and 2 were
modelled by homology to Vip3Aa (pdb:6tfk) using the SWISS model server.
Residues 337-803, corresponding to domains 3,4 and 5, from the Vip3Bc1 (pre-
toxin) model generated in this study were attached to residues 105-336 using
COOT in order to generate a complete model for Vip3Bc1act. This model is
deposited in the PDB as 6YRG. A second model for Vip3Bc1act was prepared that
describes only residues visible in the experimental map. This excludes residues
105–140, which appear to be disordered in the specimen used here. The second
model is deposited in the PDB as 7NTX.
Liquid chromatography-mass spectrometry. Protein desalting and mass analysis
was performed by LC-MS using an M-class ACQUITY UPLC (Waters UK,
Manchester, UK) interfaced to a Xevo QToF G2-XS mass spectrometer (Waters
UK, Manchester, UK). Samples were diluted to 5 µM using 0.1% TFA. 1 µL of the 5
µM sample was loaded onto a MassPREP protein desalting column (Waters UK,
Manchester, UK) washed with 10% solvent B in A for 5 min at 25 µLmin. After
valve switching, the bound protein was eluted by a gradient of 2–40% solvent B in
A over 1 min at 25 µL min. The column was subsequently washed with 95% solvent
B in A for 6 min before re-equilibration at 5% solvent B in A ready for the next
injection. Solvent A was 0.1% formic acid in water, solvent B was 0.1% formic acid
in acetonitrile.
The column eluent was directed into the mass spectrometer via a Z-spray
electrospray source. The MS was operated in positive TOF mode using a capillary
voltage of 3.2 kV, sample cone of 20 V and source offset of 80 V. The source
temperature was 100 °C and desolvation was 250 °C. Mass calibration was
performed by a separate injection of [Glu]-fibrinopeptide b at a concentration of
250 fmol µL. Data processing was performed using the MassLynx v4.1 suite of
software supplied with the mass spectrometer.
Preparation of LUVs. CF-loaded LUVs were prepared from a lipid mixture of
DOPC and DOPE in a molar ratio 6:4 dissolved in chloroform. First, 100 µL of the
lipid solution were dried under high vacuum overnight to get a dry lipid thin film. 5
(6)-CF was encapsulated within LUVs at sufficient concentration to be self-
quenched by rehydration of the lipid film with 500 µL of 50 mM TrisHCl, 120 mM
CF at pH 8.5 to form a suspension of polydisperse multilamellar liposomes. This
liposome suspension was then subjected to 5 freeze-thaw cycles and extruded 11
times through a 400 nm pore size polycarbonate membrane (Whatman Interna-
tional Ltd) using a LiposoFast liposome extruder (Avestin Inc). The final sus-
pension of monodisperse LUVs was passed through a Sephadex G-25 column to
remove the unencapsulated CF via SEC.
Determination of lipid concentration. The phospholipid concentration in the
LUVs sample was determined by a standard phosphorus assay. Briefly, 70 μL ali-
quots of the vesicle sample were added to sample test tubes and calibration samples
were created using a phosphorous standard solution (0, 0.0325, 0.065, 0.114, 0.163,
0.228 μM phosphorous). 450 μL 8.9 N H2SO4 (aq) were added to each test tube and
heated to 215 °C for 25 min. After cooling the samples at room temperature, 150 μL
H2O2 (30% w/v) were added and the tubes were heated again at 215 °C for 30 min.
Test tubes were allowed to cool before adding 3.9 mL deionised water, 0.5 mL 2.5%
ammonium molybdate (VI) tetrahydrate solution and 0.5 mL 10% ascorbic acid
solution then heating at 100 °C for 7 min. Finally, the adsorption of each sample
was measured at 820 nm and the concentration of phosphorous (and therefore
phospholipid) in the LUVs sample was determined by comparison to the cali-
bration curve created using the phosphorous standards.
5(6)-Carboxyfluorescein release assay. CF-loaded LUVs were suspended in
isotonic buffer (50 mM TrisHCl, 150 mM NaCl, pH 8.5) reaching a lipid con-
centration of 2.0 ± 0.5 µM and incubated for 30 min with different concentrations
of Vip3Bc1 before and after trypsin treatment. The CF release from the liposomes
was detected by measuring the fluorescence intensity from 500 nm to 600 nm of the
samples excited at 492 nm, using a FluoroMax-Plus spectrofluorimeter (Horiba
Scientific). Three independent replicates were taken for each data point shown in
Fig. 2. The results are presented as normalised percentage of dye release calculated
from the fluorescence emission peaks at 514 nm (In). Samples of LUVs non-
exposed to protein were used as baseline signal (I0) and values for 100% dye release
(Imax) were obtained by lysing the LUVs with 0.15% (w/v) of Triton X-100. The






Data supporting the findings of this paper are available from the corresponding authors
upon reasonable request. A reporting summary for this Article is available as a
Supplementary Information file.
EM density maps have been deposited in the Electron Microscopy Data Bank under
accession number EMD-10888 for Vip3bc1 and EMD-10889 for Vip3Bc1act and atomic
coordinates into the Protein Data Bank under accession number 6YRF for Vip3bc1 and
6YRG and 7NTX for Vip3Bc1act. Source data are provided with this paper.
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